MatthewHaltomMD
Pulmonology • Memphis, TNCritical Care Medicine, Sleep Medicine
Vanderbilt University Medical Center
Dr. Haltom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5050 Poplar Ave
Ste 800
Memphis, TN 38157Phone+1 901-276-2662Fax+1 901-274-2033
Summary
- Dr. Matthew Haltom is a pulmonary and critical care physician from Memphis, TN. He received his medical degree from University of Tennessee Health Science Center College of Medicine before doing Internal Medicine and Pulmonary & Critical Care Medicine in Memphis. He is currently doing a Sleep Medicine fellowship at Vanderbilt University Medical Center in Nashville, TN.
Education & Training
Vanderbilt University Medical CenterFellowship, Sleep Medicine, 2023 - 2024
University of TennesseeFellowship, Pulmonary Disease and Critical Care Medicine, 2020 - 2023- University of TennesseeChief Residency, Internal Medicine, 2019 - 2020
- University of TennesseeResidency, Internal Medicine, 2016 - 2019
University of Tennessee Health Science Center College of MedicineClass of 2016
Certifications & Licensure
TN State Medical License 2024 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 3 citationsThe great masquerader: Kikuchi-Fujimoto disease presenting as fever of unknown origin.Jay Patel, Matthew B. Haltom, Christopher Jackson
Journal of the National Medical Association. 2021-08-06 - Culture Negative Endocarditis Masquerading as Recurrent Supraventricular TachycardiaBrianna N. Saadat, Matthew B. Haltom, Desiree C. Burroughs-Ray, Christopher Jackson
Journal of the National Medical Association. 2021-06-01 - Safety of Baricitinib 4 mg for the Treatment of Moderate to Severe Rheumatoid Arthritis.Tracey D Dabal, Matthew B. Haltom, Puja P Patel, Christine K Son, Kiran Joglekar
Southern Medical Journal. 2021-05-01
Journal Articles
- Choice of Intravenous Crystalloid Fluid and Mortality in Critically Ill Adult Patients: Review Article and Meta-AnalysisJackson, C. Patel, S. Haltom, M. Iyer, P. Odeesh, M. Bradsher, R. Kamal, S. Seth, A., Southern Medical Journal, 7/2019
Abstracts/Posters
- Massive Left Ventricular Thrombus with Thromboembolic Phenomenon due to Alcoholic Cardiomyopathy: A Case Report and Review ArticleMatthew Haltom; Nurrdein Almaddah; Ikechukwu Ifedili; Ryan Lam; Rami Khouzam; Raza Askari; Anthony Holden; Uzoma Ibebuogu, Southern Society of Clinical Investigation, New Orleans, Louisiana
- Long-term Efficacy and Safety of Baricitinib in the Treatment of Rheumatoid Arthritis: A Systematic Review and Meta-AnalysisJackson, C. Dabal, H. Haltom, M. Son, C. Joglekar, K. Chumpia, M. Groeschell, C. Khan, M. Seth, A., Southern Medical Association, Charleston, South Carolina, 10/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
